Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis
Year: 2019
Type: article
Abstract: -acetylcysteine or deoxyribonuclease. These findings indicate that early CF lung disease is characterized by an increased mucus burden and inflammatory markers without infection or structural lung disease and suggest that mucolytic and anti-inflammatory agents should be explored as preventive therapy.
Source: Science Translational Medicine
Authors: Charles R. Esther, Marianne S. Muhlebach, Camille Ehre, David B. Hill, Matthew C. Wolfgang, Mehmet Kesimer, Kathryn A. Ramsey, Matthew R. Markovetz, Ian C. Garbarine, M. Gregory Forest, Ian Seim, Bryan Zorn, Cameron B. Morrison, Martial F. Delion, William R. Thelin, Diane Villalon, Juan R. Sabater, Lidija Turkovic, Sarath Ranganathan, Stephen M. Stick, Richard C. Boucher
Institutions: University of North Carolina at Chapel Hill, The Kids Research Institute Australia, The University of Western Australia, Parion Sciences (United States), Mount Sinai Medical Center, The University of Melbourne, Murdoch Children's Research Institute, Princess Margaret Hospital for Children
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: National Science Foundation, Cystic Fibrosis Foundation, National Institutes of Health, National Health and Medical Research Council, National Heart, Lung, and Blood Institute, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Environmental Health Sciences, North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill
Awards: G1278906371, Purines as Biomarkers of Respiratory Disease, Synthesis of Effective and Safe Mucolytics for Pulmonary Disease, G3402746032, G3541119087, G3599213994, G3728429041, A Mathematical-Experimental Strategy to Discern the Molecular Basis of "Successful Mucus", Mucus and hypoxia in heterogeneous and progressive CF lung disease, Pulmonary Surface Liquid Homeostasis, Multiscale Biochemical/Biophysical Integration of Pulmonary Mucus Transport, G5607280748, G6050369393, Mucous in Heterogeneous and Progressive Early Cystic Fibrosis Lung Disease, Mucus Adhesion to Epithelial Cells and its Mobilization in COPD and CF, Development of Novel Mycolytic Therapies for Lung Disease, Centre for research in early lung disease, UNC Center for Environmental Health and Susceptibility, UNC Cystic Fibrosis Research and Translation Core Center
OpenAlex ID: W2932017142
